Photo Credit: J Am Coll Cardiol. Central Illustration (adapted). High-risk, nonstenotic intracranial plaque appears to be a more important cause of embolic stroke of undetermined source (ESUS) than ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...

Medically reviewed by Huma Sheikh, MD Key Takeaways High blood pressure and atherosclerosis are common causes of strokes.

Data Supports Previous Preclinical Results Indicating Improvement in Stroke Recovery Following Oral Arimoclomol Administration LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a ...

Key states, including California and Texas, lead in demand due to advanced healthcare systems and aging populations U.S. Embolic Protection Device Market U.S. Embolic Protection Device Market Dublin, ...

MicroPort NeuroTech Limited ($HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...